Navigation Links
Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to Chemotherapy
Date:6/3/2013

s European prospective, observational study included 2,310 patients with solid tumors, lymphomas or myelomas. The majority of patients (>80 percent) enrolled in this study achieved a pre-defined hemoglobin (Hb) response with Retacrit in a real-world clinical setting.   Retacrit was well tolerated in this study with an overall rate of thrombotic events at 3.5 percent. In this observational study, no epoetin alfa biosimilar-related deaths were reported.1

View the full results at: Elisabeth Luporsi-Gely, Pierre-Louis Soubeyran, Mauricette Michallet; Centre Alexis Vautrin, Nancy, France; Institut Bergonie, Bordeaux, France; Centre Hospitalier Lyon Sud, Pierre Bénite, France; Epoetin biosimilars in the management of anemia secondary to chemotherapy in patients with solid tumors, lymphomas, and myelomas: The ORHEO study; Poster session presented at 2013 ASCO Annual Meeting

"Patients in the study showed a very good rate of response to Retacrit and tolerated it well," said Dr. Elisabeth Luporsi-Gely , of ICL Alexis Vautrin, Vandoeuvre-les-Nancy, France, and one of the study's principal investigators. "This is the first post-marketing observation study conducted in France for a biosimilar, and the results reinforce why there is a growing acceptance of biosimilars. The introduction of biosimilars has offered new options for patients and has helped bring cost savings to the healthcare system."

In addition to the results from this study, several Hospira-related studies (view links below) were presented at the ASCO Annual Meeting, including:


SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
2. Hospira dévoile sa stratégie appareil mondiale
3. Hospira enthüllt weltweite Gerätestrategie
4. Hospira revela estrategia global para sus dispositivos
5. Hospira revela estratégia global para dispositivos
6. Hospira Reports First-Quarter 2013 Results
7. Hospira Unveils Global Device Strategy
8. Hospira Names Matthew R. Stober Senior Vice President of Operations
9. Hospira to Host Conference Call for First-Quarter 2013 Results
10. Hospira Announces Executive Changes
11. Hospira Reports Fourth-Quarter and Full-Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... TUCSON, Ariz. , July 31, 2014 ... the public can watch the implantation of the SynCardia ... report paper and matching video posted on the Journal ... the video and read the paper on the SynCardia ... The 16-minute video accompanies "Implantation of the SynCardia ...
(Date:7/31/2014)... Ill. , July 31, 2014 ... the head of corporate and employee communications in ... Jeff Winton , senior vice president, chief ... responsible for developing and leading corporate brand initiatives ... goals across North and South America ...
(Date:7/31/2014)... , July 31, 2014 TB ... and developing better, faster and affordable treatments, announced ... Senior Vice President, External Affairs. Mr. Brock comes ... Head of Major Donor Relations for WWF International ... his role, Mr. Brock will guide the TB ...
Breaking Medicine Technology:How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced today that ... Conference to be held March 15-17, 2011 at the Loews ... Chief Executive Officer, is scheduled to present an overview of ... ET. To listen to the audio web cast ...
... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today ... two upcoming investor conferences:   Kathryn Falberg, ... the ROTH 23rd Annual OC Growth Stock Conference in Dana ... Pacific Time Bruce Cozadd, the company,s chairman and chief ...
Cached Medicine Technology:Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference 2
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... company, has launched a new service named ‘Remove Bad ... against which bad reviews are published on various review ... study about the world of internet marketing, the sites ... by its competitors in order to tailor the service. ...
(Date:7/31/2014)... 2014 Thousands of independent community ... country have come together today to kick off ... tradeshow. , "ThoughtSpot 2014 is Good Neighbor Pharmacy’s ... tools to help their businesses thrive," stated AJ ... a long-standing commitment to independent community pharmacies, and ...
(Date:7/31/2014)... 31, 2014 T.E.N., a technology ... honored finalists and winners Wednesday evening, July 30, ... Awards Gala at the Westin St. Francis in ... information security for the BlackLine Systems, was selected ... Award winner for the ISE® West Region. As ...
(Date:7/31/2014)... HealthDay Reporter WEDNESDAY, July ... boy" disease can often be cured with a stem cell ... critical, a new study finds. Severe combined immunodeficiency (SCID), ... group of rare genetic disorders that all but eliminate the ... infections. The term "bubble boy" became popular after a ...
(Date:7/31/2014)... News) -- Recovery time after surgery may be reduced ... according to a new study. The study,s Irish ... inflammatory response, reducing the amount of time surgical patients, ... particularly true among people who tend to have healing ... widely prescribed medications in the world. While they are ...
Breaking Medicine News(10 mins):Health News:Reputation Management India Launches a New Service Called ‘Remove Bad Reviews’ 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 2Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 3Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 4Health News:Early Stem Cell Transplant Vital in 'Bubble Boy' Disease 2Health News:Early Stem Cell Transplant Vital in 'Bubble Boy' Disease 3Health News:Cholesterol Drugs May Speed Healing After Surgery 2
... Sept. 1 (HealthDay News) -- The intensity of exercise, not ... chances of living a longer life, a new study suggests. ... men with high levels of cycling intensity lived 5.3 years ... than men with low intensity. Among female cyclists, those ...
... DARIEN, IL A natural yellowing of the eye lens that ... group of test volunteers, according to a,study in the September 1 ... lens discoloration worsened with age, so did the risk of insomnia. ... explain why sleep disorders become more frequent with increasing age," said ...
... adults aged 15 to 44 increased up to 37% ... by researchers at the Centers for Disease Control and ... of Neurology , a journal of the American Neurological ... in the prevalence of hypertension, diabetes, obesity, lipid disorders, ...
... in the September issue of the Journal of the ... optimization in chest computed tomography (CT) scans. Chest CT is ... diagnose the cause of clinical signs or symptoms of the ... fever. Regardless of the body region being scanned, ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, ... using electronic medical records instead of paper files could ... Diabetic patients "did better and improved faster" at ... e-records, said study author Dr. Randall D. Cebul, a ...
... WEDNESDAY, Aug. 31 (HealthDay News) -- A new type of ... tumor cells without harming normal cells is showing promise in ... 23 patients with advanced cancers that had spread to multiple ... received an intravenous infusion of a virus called JX-594 at ...
Cached Medicine News:Health News:Aging eyes linked to sleepless nights, new study shows 2Health News:Increased prevalence of stroke hospitalizations seen in teens and young adults 2Health News:Electronic Medical Records Might Boost Diabetes Care 2Health News:Electronic Medical Records Might Boost Diabetes Care 3Health News:Trial of Cancer-Fighting Virus Shows Promise 2Health News:Trial of Cancer-Fighting Virus Shows Promise 3
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The uncemented hip joint prosthesis system...
Medicine Products: